Shattuck Labs Inc Sustainability Reports
Shattuck Labs, Inc. is a clinical-stage biotechnology company that develops immunotherapy medicines and treatments. The company specializes in creating therapeutic antibodies and fusion proteins designed to treat inflammatory diseases, autoimmune disorders, and cancer.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG00V776CR6
2 reports from 2023 to 2024